Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress

Author： Dawson Lee A   Porter Roderick A  

Publisher： Future Science

ISSN： 1756-8927

Source： Future Medicinal Chemistry, Vol.5, Iss.13, 2013-09, pp. : 1525-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in the development of pandemic influenza vaccines and their production technologies

By Kiselev O.  

Applied Biochemistry and Microbiology, Vol. 46, Iss. 9, 2010-12 ,pp. : 815-830

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9

By Vollmer Jörg  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 673-682

Informa Healthcare

Access to resources Recommend Favorite

Protein-Protein Interactions: Recent Progress in the Development of Selective PDZ Inhibitors

By Ducki Sylvie   Bennett Elizabeth  

Current Opinion in Chemical Biology, Vol. 3, Iss. 2, 2009-05 ,pp. : 146-158

Elsevier

Access to resources Recommend Favorite

Protein-Protein Interactions: Recent Progress in the Development of Selective PDZ Inhibitors

By  

Current Chemical Biology, Vol. 3, Iss. 2, 2009-05 ,pp. : 146-158

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the development of paper-based diagnostics for low-resource point-of-care settings

By Byrnes Samantha   Thiessen Gregory   Fu Elain  

Bioanalysis, Vol. 5, Iss. 22, 2013-11 ,pp. : 2821-2836

Future Science

Access to resources Recommend Favorite